| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Abdullah A Algarni | |
| P2860 | cites work | Monitoring the antiplatelet action of aspirin | Q28188378 |
| Drug insight: aspirin resistance--fact or fashion? | Q28213070 | ||
| Antiplatelet medication after liver transplantation: does it affect outcome? | Q28222511 | ||
| Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? | Q28222514 | ||
| Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats | Q33241234 | ||
| Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency | Q33242018 | ||
| Enoxaparin and bleeding complications: a review in patients with and without renal insufficiency | Q33977626 | ||
| Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes | Q34137248 | ||
| Antithrombin effect on coagulation and fibrinolytic profiles after living donor liver transplantation: a pilot study | Q34406748 | ||
| Low-molecular-weight heparins | Q34437479 | ||
| Cardiovascular morbidity and mortality after orthotopic liver transplantation | Q34581979 | ||
| Haemostatic abnormalities in patients with liver disease | Q34749870 | ||
| Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors | Q34965276 | ||
| Minimizing blood loss in liver transplantation: progress through research and evolution of techniques | Q36262769 | ||
| Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. | Q36893485 | ||
| Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver | Q38317041 | ||
| Administration of dalteparin based on the activated clotting time for prophylaxis of hepatic vessel thrombosis in living donor liver transplantation | Q43241176 | ||
| No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. | Q43879938 | ||
| In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation | Q44247284 | ||
| The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration | Q44307922 | ||
| Use of enoxaparin in end-stage renal disease | Q44906610 | ||
| An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis | Q45887924 | ||
| Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation | Q46824253 | ||
| Endovascular stent placement in patients with hepatic artery stenoses or thromboses after liver transplant | Q47925074 | ||
| Hepatic artery thrombosis after adult liver transplantation. | Q52951233 | ||
| Hepatic artery thrombosis in living related liver transplantation. | Q54515897 | ||
| Etiology and management of hepatic artery thrombosis after adult liver transplantation | Q61796561 | ||
| A hypercoagulable state follows orthotopic liver transplantation | Q68921690 | ||
| Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? | Q69077186 | ||
| Prevention of hepatic artery thrombosis in pediatric liver transplantation | Q71544329 | ||
| Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans | Q73907435 | ||
| Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients | Q73954997 | ||
| Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation | Q74500542 | ||
| Anticoagulant therapy in living-related liver transplantation | Q78514275 | ||
| Anticoagulant therapy against hepatic artery thrombosis in living donor liver transplantation | Q78693537 | ||
| Is chronic liver disease associated with a bleeding diathesis? | Q80233018 | ||
| Treatment of hepatic artery thrombosis after orthotopic liver transplantation | Q81058226 | ||
| Treatment of early hepatic artery thrombosis after liver transplantation | Q85089675 | ||
| Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation | Q85787823 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| liver transplantation | Q1368191 | ||
| anticoagulation | Q63279445 | ||
| hepatic artery thrombosis | Q105323112 | ||
| P304 | page(s) | 1238-43 | |
| P577 | publication date | 2015-05-28 | |
| P1433 | published in | World Journal of Hepatology | Q27723328 |
| P1476 | title | Anticoagulation and antiplatelets as prophylaxis for hepatic artery thrombosis after liver transplantation | |
| P478 | volume | 7 |
| Q57122149 | Analysis of Ischemic Cholangiopathy After Treatment of Arterial Thrombosis in Liver Transplantation in Our Series |
| Q48208752 | Bleeding and thrombotic complications of pediatric liver transplant |
| Q90388064 | Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management |
| Q38981087 | Intraoperative Management of High-Risk Liver Transplant Recipients: Concerns and Challenges |
| Q90671469 | Liver function after transplantation in the assessment of the coagulation system and the concept of antithrombotic therapy |
| Q36204485 | Microscope-assisted hepatic artery reconstruction in adult living donor liver transplantation-A review of 325 consecutive cases in a single center |
| Q91748168 | Post-transplantation Outcomes in Patients with PA or MMA: A Review of the Literature |
| Q55344899 | Renal Infarction during Anticoagulant Therapy after Living Donor Liver Transplantation. |
Search more.